A new documentary by comedian and filmmaker Nathan Fielder and director Lance Oppenheim is bringing renewed attention to Elizabeth Holmes, the former Theranos chief executive convicted of defrauding investors over claims about the company’s blood-testing technology.
Titled You Can See Everything, the documentary follows Holmes and her family during the 34 days before she reported to prison in 2023. The film is scheduled for theatrical release on October 16, 2026, according to distributor A24.
The project first attracted widespread attention after a surprise screening at the Telluride Film Festival on September 6, before its subsequent presentation at the New York Film Festival. Its unusual approach combines close observation of Holmes’ private life with Fielder’s distinctive, often uncomfortable style of questioning and interaction.
The film’s approach is unusual because it gives viewers access to a period when Holmes was preparing to leave her family and begin serving her prison sentence. Fielder and Oppenheim filmed her household over an extended period, with the production eventually developing into a feature-length documentary lasting nearly three hours.
Holmes founded Theranos with the promise that its technology could conduct a wide range of medical tests using only a small amount of blood. The company attracted substantial investor funding and was once valued at about $9 billion. Its claims later unravelled amid scrutiny of its testing technology, leading to criminal charges against Holmes and former company executive Ramesh “Sunny” Balwani.
In 2022, Holmes was convicted on four counts related to defrauding investors. She began serving her prison sentence in 2023. Balwani was separately convicted of fraud and conspiracy.
Fielder, known for the comedy series Nathan for You and The Rehearsal, has built a reputation for blending awkward social encounters, staged situations and documentary-style filmmaking. Oppenheim, whose previous work includes documentaries about unconventional communities, co-directed the project. Their collaboration places Holmes’ story within a broader examination of credibility, public image and the gap between how people present themselves and how others interpret their behaviour.
Speaking after a screening at the New York Film Festival, Fielder described the experience of filming Holmes as difficult to interpret. He said the filmmakers frequently disagreed about the meaning of events they had witnessed, a tension that helped shape the documentary.
The production also became strained towards its later stages. In an interview published by People on October 7, the filmmakers said neither Holmes nor her partner, Billy Evans, had watched the completed film. Fielder said communication with Evans had broken down after disagreements over the filmmaking process. Those comments reflect the directors’ account of the production; the documentary itself is scheduled to reach cinemas the following week.
Holmes’ participation does not mean she has publicly abandoned her position on the case. She has maintained her innocence despite her conviction. The documentary’s account of her private life is therefore distinct from the findings of the criminal proceedings, which established her guilt on the investor-related counts.
The film arrives amid continuing public interest in the Theranos scandal, which became a prominent example of the risks associated with exaggerated technology claims, weak oversight and investor confidence in high-profile founders. Its release may renew discussion of how Holmes built her public image, how the company attracted funding, and why its claims survived scrutiny for so long.
With its October 16 theatrical release approaching, You Can See Everything offers a new documentary perspective on Holmes’ final weeks before imprisonment. Whether viewers interpret the film as an intimate portrait, a study of public performance or an examination of the difficulty of determining truth from appearances is likely to remain part of the conversation surrounding the project.